Back to Search

MICHAEL VARNEY, MD

MD

Internal Medicine Physician

NPI: 1124023510IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

33319(NC)16343(SC)
General Practice Physician

General Practice

Code: 208D00000X

33319(NC)

CMS Specialties

PrimaryFAMILY PRACTICE

Education

WRIGHT STATE UNIVERSITY BOONSHOFT SCHOOL OF MEDICINE

Class of 1987

Research & Publications (20)

Omega 3 fatty acids reduce myeloid progenitor cell frequency in the bone marrow of mice and promote progenitor cell differentiation.
PMID 19296839·Lipids Health Dis·2009
7-preclinical
Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion.
PMID 19585580·Int J Cancer·2010
7-preclinical
Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis.
PMID 19293256·Clin Cancer Res·2009
7-preclinical
Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis.
PMID 19147552·Cancer Res·2009
7-preclinical
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion.
PMID 19401689·Br J Cancer·2009
8-other
Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysis.
PMID 19590968·Clin Exp Metastasis·2009
7-preclinical
Effects of the PPARgamma agonist troglitazone on endothelial cells in vivo and in vitro: differences between human and mouse.
PMID 19285096·Toxicol Appl Pharmacol·2009
4-observational
In vivo saturation binding of GABA-A receptor ligands to estimate receptor occupancy using liquid chromatography/tandem mass spectrometry.
PMID 19152227·Biopharm Drug Dispos·2009
7-preclinical
HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
PMID 19392788·Tissue Antigens·2009
8-other
Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation.
PMID 19038005·Cancer Sci·2009
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
2246 HIGHWAY 17
LITTLE RIVER, SC 29566

Locations (2)

Practice Location

2246 HIGHWAY 17, LITTLE RIVER, SC
(843) 663-2220

Practice Location

4402 SHIPYARD BLVD, WILMINGTON, NC
(910) 452-1400

Quick Facts

NPI
1124023510
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
3
Locations
2
Years in Practice
39
Publications
20

Are you this provider?

Claim Your Profile